MANNKIND GETS F.D.A. OK

June 28, 2014 1:41 AM

5 0

MANNKIND GETS F.D.A. OK

MannKind Corp. announced Friday afternoon that it has received long-sought-after FDA approval for its candidate diabetes treatment, Afrezza.

The third time was the charm for the Valencia-based company and its revolutionary insulin powder. Delivered with a whistle-sized inhaler, it acts more rapidly than Eli Lilly’s or Novo Nordisk’s injectable insulins and could reduce or eliminate the need for needles completely, depending on the patien...

Read more

To category page

Loading...